Rhenovia Pharma RSS En http://www.rhenovia.com/pages/home.php?lang=En <![CDATA[Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.]]> 2010-09-04T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=340&lang=En <![CDATA[DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.]]> 2010-08-29T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=338&lang=En <![CDATA[Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and noncompetitive antagonists]]> 2010-08-26T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=336&lang=En <![CDATA[Rhenovia invited by UBIFRANCE to present its unique neuronal biosimulation platform at the French Biotech Tour in Philadelphia, 14 September 2010.]]> 2010-08-21T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=334&lang=En <![CDATA[ August 20, 2010 2:36 AM ET Pharmaceuticals Rhenovia Pharma SAS:Key developments for Rhenovia Pharma cited in Bloomberg Business Week]]> 2010-08-20T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=332&lang=En